Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Karo Bio enrolls first patient in AKKA study

Oct. 5, 2011

Phase IIb trial of SB-509 does not meet primary or secondary endpoints

Oct. 4, 2011

Studies assess 2-year and sustained-release ONO-5334 therapy

Oct. 4, 2011

GlaxoSmithKline reports new SAP-binding proteins

Oct. 3, 2011

FDA reviews safety of drospirenone-containing birth control pills

Oct. 3, 2011

Biodel announces phase I data on experimental insulins

Sep. 30, 2011

Aegerion gives update on European filing for lomitapide

Sep. 30, 2011

Synageva BioPharma expands ongoing study in LAL deficiency

Sep. 30, 2011

Takeda files for approval of TAK-085 in Japan

Sep. 29, 2011

New PPAR-gamma agonists synthesized in Japan

Sep. 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...